Clinical Trials Browser

Phase 2 × Non Small Cell Lung Cancer Metastatic × pembrolizumab × Clear all

NCT05117242 2025-11-06

Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

Phase 2 Active not recruiting

Non Small Cell Lung Cancer Metastatic